Panacea Biotec Ltd – 531349 – Announcement under Regulation
30 (LODR)-Press Release / Media Release
Press Release – Key Highlights of the financial results for the quarter ended June 30, 2019 – Revenue growth of 28% and EBITDA growth of 251 %
This is in continuation to our earlier letter dated 12.08.2019, along with the copy of Standalone and Consolidated Unaudited Financial Results (Provisional) of the Company for the quarter ended June 30, 2019, as reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 12.08.2019.
Panacea Biotec is now delighted to attach a copy of the Press Release showing the key highlights of the financial results for the quarter ended June 30, 2019, being released to media, etc. in this regard.
Click here to get Pdf link: